HLN Phil Trading Inc.

Visit of Philippines Ambassador to our Arlem Mines




1. CII delegation was taken to the Philippines. The delegates taken were:

  1. Mr. Haresh Melwani (M/s H.L.Nathurmal)
  2. Mr. Kapil Kare (Director of Kare laboratories)
  3. Mr. Hede (The president of CII)
  4. Sameer Salgoakar (for Mining)
  5. Mr. Shinde (M/s Dempos ltd)
  6. Mr. Prakash Jalan (M/s Linc Pen Industries Ltd)

The main agenda of the delegation was to understand and explore the various business opportunities which existed on both the countries and on long term corporation particularly in mining. During the course of discussion, it was evolved at pharmaceutical, mining and allied services from India to Philippines could be potentially bigger market. As India has a very sound and solid pharma industry in place and the Hub for which is Goa, Goa has excellent Port facilities..

It is supported that pharma can be a major area for mutual cooperation

  • Huge population in the Philippines
  • Average per capita income
  • And high cost of medicines prevalent in the Philippines presently.
  • Role of PITC.

The delegation was taken on the 8th of August 2005 with a mission of trade opportunities in goa.the meeting was with the Board of investment,BFAD,philliphines export zone authority(PEZA) There was a special dinner organized for the delegations with the president

2. Meeting with BOI



 

The Board of Investment meeting was attended by all the delegates from India

3. Meeting the PCCI

During the meeting with Board of investment (BOI).Lot of emphasis was laid whereby industries of varied sectors were invited to visit in Philippines. Enclosed is the photo of Mr.Jalan, Mr. Hede, Mr. Kare, Mr. Melwani, Mr. Salgoakar, Mr. Jasraj, and Mr. Gawde from left to right

4. MOU with Trans-Asia signed

 
 
 
 
 
 

5. Signed MOU ACCR with PITC

In the course of this visit a Memorandum of Understanding (MOU) was signed between Mr. Haresh Melwani of M/s HLNathurmal and Philippine International Trading Corporation (PITC) on the 4th October 2005 whereby M/s HLNathurmal is an accredited supplier to the PITC in the Philippines.



 

6. Mr. Fidel .V. Ramos visit to India

As a follow-up to the delegation, initiative was taken by Mr. Haresh Melwani (proprietor of M/s HLNathurmal). A high level Delegation of Various Captain of Industry from Philippines was organized on
16th January at the Taj President, in Mumbai Realizing the trade potential between the 2 countries this delegation was headed by none Other than Mr. Fidel V Ramos, Former President of the Republic of Phillippines.Which substantiates the importance given by the Philippines for Business Corporation with India and included Ms. Celesto Ilagan (BOI), Mr. Rizalino Navarro (RCBC Bank) etc.

7. Signed a MOU with Mr. Rohas (President of federation on Dextrose plant and Biotech activities and sugar chemicals)





8. Certificate of Accredition

9. The certificate of Securities and Exchange Commission

10. License to Operate as Drug Distributor / Importer / Wholesaler

Click Here to view/download (pdf)

11. Visit of Mr. Abraham Pascual of Pascual Laboratories Inc.

Giving and Impetus to the visit Mr. Fidel V Ramos, Former President of the republic of Philippines to India .a ;lot of interest has been generated in India pharmaceutical Industraries and Especially Goa which is a Pharma Hub.
Mr. Abraham Pascaul of Pascual Lab Inc.  The leading and one of the oldest pharma manufacturers in the Philippines visited Goa on the 16th Jan 2006,to explore further business corporation in India. During his visit he visited

  1. M/s Sandu Pharmaceuticals Ltd (where M/s H.L.Naturmal is the sole distributor to the Philippines).a ISO 9001/14000 accredited plant which is one of the oldest Ayurvedic/Herbal company in India.
  2. And Also M/s Kare Laboratories ltd.

for the purpose of exploring corporation /joint venture etc. for both Herbal and Allopathy products.

12. Opened Botika NG. BAYAN in Bacolod City Called Blue gold Pharmacy


13. Coming up

MOU with Trends Agri Mining

MOU with PQM (Pinoy Quality Medicines)-Group of 4 Pharma Manufacturing Companies)
-schedule

Having totally over 125 years of pharma manufacturing experience in the Philippines, and also to supply raw material with food grade for production with onward supply to the PITC.

  • Introducing Rasna in the Philippines for marketing and substitute production under a MOU with Mr. Royas.

14. Activities in the Pharma Sector in Goa - India

Considering the need to diversify its investment portfolio from the usual financial instruments such as stocks, bonds and real estate holdings, it was decided to invest in high growth areas relevant to the Goan Industrial Scenario.  We would identify poor performing companies manufacturing various Pharmaceutical products and take up position as a Silent Investor and bring in professional management to turn around all the units, into profitable ventures.

Our units are all GMP certified, have unionized workforce and are exemplary employers having a good reputation as responsible corporates in the Goan context. The products are manufactured to meet the stringent norms for supply to many multinationals.  Approximately 60% of our current output is exported to America and Europe.

The entrepreneurial inputs are provided only during the nursing stage of the poor performing unit and once stability is restored; a team of professionals, generally drawn from the rank and file, are handed over the day – to – day management under the supervision of a panel of peers from the Head Office. An interesting feature of the control system is that only significant deviations from the planned output are reported to Head Office.

Other Pharmaceutical Investments

The Kare Group of Companies (Associated as a Distributor in the Philippines):
The Kare Group of Companies is one of the most progressive Industrial and Trading House and has a history of nearly 60 years, particularly in the Pharmaceutical business.  Founded in 1932 by late Mr. Govind Ramnath Kare, the Group has grown tremendously from a small chemist shop in Margao at a pharmaceutical group well known for its commercial and industrial activities.
Now, under the leadership of the Chairman, Mr. Ramnath G. Kare, the group has taken rapid strides towards becoming a comprehensive pharmaceutical group matching global standards through international standard manufacturing facilities. This progress has been achieved through acquisitions and development of new manufacturing facilities. The first plant, DCI Pharmaceuticals Pvt. Ltd., was started in 1971 in Margao, Goa.


In 1997, the Group set up a new manufacturing plant, Kare Labs Pvt. Ltd. at Verna, Goa for an investment of Rs 150 million. This facility is state of the art and has been approved by multinational companies like Abbott, E-Merck and Aventis, besides leading Indian Companies.

The group comprises of 3 manufacturing companies, DCI Pharmaceuticals Pvt. Ltd., Kare Labs Pvt. Ltd. and Motiff Laboratories Pvt. Ltd. The Group has high volumes capacities and manufactures formulations in dosage forms including, Tablets (Plain, Sugar & Film coated), Ointments/Creams/gels. Liquid orals, Injectables, Ophthalmic and Ear Drops. Capsules (Beta-Lactum & Non-Beta Lactum), Beta-Lactum Dispersible Tablets, Beta Lactum Liquid orals, Dry Syrups, External Lotions, and External Dusting Powders. All facilities are equipped with sophisticated machinery and manned by highly qualified personnel. Kare Labs Pvt. Ltd. and DCI Pharmaceuticals Pvt. Ltd. are certified under the WHO GMP certification scheme.
Currently, the group is primarily engaged in Contract Manufacturing Activities for reputed Multinational and Indian Companies like Abbott, Cipla group, Ranbaxy, Morepen Laboratories, Wockhardt, Nicholas Piramal, Indoco Remedies, etc. Some products of the group are being supplied to Central Government Hospitals, AFMSDs, State and semi-Government Institutions, etc. It is also exporting its products to some of the neighboring countries.

Sandu Pharmaceuticals Ltd. (Associated as a Distributor in the Philippines)
M/s Sandu Pharmaceuticals Ltd. has acquired a unique position and reputation as a leading enterprise in the field of Ayurveda.  The company is engaged in manufacturing quality Herbal products and is available through an extensive distribution network in India as well as the overseas markets.
The Company has steadily grown @ 20% in the last 3-5 years.  The sapling that was planted over 20 years ago has grown into a wonderful tree adding rich contributions in the field of Ayurveda.  Sandu Pharmaceuticals Ltd. is aware of their social obligations and has always come forward giving generous assistance to financial and cultural aspects of community at large, and also scientific and religious institutions.  Company has been operating two dispensaries in Mumbai to render free health service to the people.

The Company has one manufacturing location at Navi Mumbai and one ultra sophisticated plant at Goa, with state of art technology developed in house, leading to increase in production capacity, that can be further augmented to required levels.

Presently the company is manufacturing over 185 products for a variety of ailments for young infants to the elderly population as well. The Company has developed new products through their own R & D efforts.  The emphasis of these products would be on better child health as well as gynecological problems and for chronic ailments i.e. arthritis, stress, hypertension.  Company’s recent introduction of Debix, a clinically researched product for diabetes has been well accepted in the market.

Claris Lifesciences Limited (Associated as a Distributor in the Philippines)

Claris Life science is an international company, in the manufacturing and marketing sterile parenteral preparation, life saving medicines and hospital products.
With emphasis on research, technology and quality, Claris offers a range of unique products and delivery system in bottles, vials, ampules, prefilled syringes, non PVC/PVC bags and oral dosage forms.
Driven by a team of scientist, pharmaceutical experts and management professionals, Claris is powered by a combination of vision, R&D capabilities, Technology know-how, international standards and manufacturing expertise. The company expertise’s in lipid-based technology has made it one of the few companies in the world to manufacture protocol. And the same is accepted world wide.

The company has a presence in more than 50 countries across Latin America, Europe, CIS, Asia Pacific, Middle East and Africa.